We are live on ! Find out more
RIGL icon

Rigel Pharmaceuticals
RIGL

113 hedge funds and large institutions have $272M invested in Rigel Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 35 increasing their positions, 30 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

155% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 11

58% more capital invested

Capital invested by funds: $172M → $272M (+$99.6M)

18% more funds holding

Funds holding: 96 → 113 (+17)

17% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 30

8% more call options, than puts

Call options by funds: $193K | Put options by funds: $179K

Holders
113
Holders Change
+17
Holders Change %
+17.71%
% of All Funds
3.01%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
28
Increased
35
Reduced
30
Closed
11
Calls
$193K
Puts
$179K
Net Calls
+$14K
Net Calls Change
+$11K

Top Buyers

1
RPAM
Rhenman & Partners Asset Management
Sweden
+$2.74M
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$1.42M
3
OAM
Oxford Asset Management
United Kingdom
+$1.28M
4
DCM
DAFNA Capital Management
California
+$989K
5
TI
Turner Investments
Pennsylvania
+$644K

Top Sellers

1
VAM
Visium Asset Management
New York
-$1.37M
2
Renaissance Technologies
Renaissance Technologies
New York
-$1.14M
3
BACM
Blue Arrow Capital Management
New York
-$1.02M
4
Norges Bank
Norges Bank
Norway
-$960K
5
BC
Broadfin Capital
New York
-$700K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$47.1M +$103K +3,764 +0.3%
BC
2
Broadfin Capital
New York
$29.4M -$700K -25,542 -3%
PAI
3
Palo Alto Investors
California
$18.5M – – –
O
4
OppenheimerFunds
New York
$17.9M – – –
Wellington Management Group
5
Wellington Management Group
Massachusetts
$17.6M +$17.3K +630 +0.1%
BIT
6
BlackRock Institutional Trust
California
$11.7M +$10.2K +371 +0.1%
NMC
7
NEA Management Company
Maryland
$11.6M – – –
Vanguard Group
8
Vanguard Group
Pennsylvania
$11M +$226K +8,237 +3%
DM
9
Deerfield Management
New York
$8.56M – – –
BFA
10
BlackRock Fund Advisors
California
$8.47M -$83.8K -3,057 -1%
D.E. Shaw & Co
11
D.E. Shaw & Co
New York
$7.41M +$1.42M +51,866 +33%
SAM
12
Senzar Asset Management
New York
$7.2M -$279K -10,170 -5%
UBS AM
13
UBS AM
Illinois
$6.98M – – –
Millennium Management
14
Millennium Management
New York
$6.49M -$413K -15,077 -8%
Dimensional Fund Advisors
15
Dimensional Fund Advisors
Texas
$5.78M +$460K +16,771 +12%
State Street
16
State Street
Massachusetts
$5.27M +$101K +3,694 +3%
DCM
17
DAFNA Capital Management
California
$3.96M +$989K +36,067 +48%
RPAM
18
Rhenman & Partners Asset Management
Sweden
$3.57M +$2.74M +100,000 New
Northern Trust
19
Northern Trust
Illinois
$3.15M -$51.5K -1,880 -2%
OAM
20
Oxford Asset Management
United Kingdom
$2.33M +$1.28M +46,737 +252%
Marshall Wace
21
Marshall Wace
United Kingdom
$2.04M +$574K +20,943 +58%
BA
22
BlackRock Advisors
Delaware
$1.96M +$5.18K +189 +0.3%
Geode Capital Management
23
Geode Capital Management
Massachusetts
$1.93M +$220K +8,037 +17%
Bank of New York Mellon
24
Bank of New York Mellon
New York
$1.78M -$104K -3,809 -7%
California Public Employees Retirement System
25
California Public Employees Retirement System
California
$1.36M – – –
1
2 3 4 5

RIGL Hedge Fund Activity: Q1 2015 in Review

113 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Rigel Pharmaceuticals (RIGL) for Q1 2015, worth a combined $272M — up 58% from $172M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new RIGL positions and 11 closed out — a net gain of 17 holders — while 35 added to existing stakes and 30 trimmed.

The largest buyer was Rhenman & Partners Asset Management, opening a new position worth an estimated $2.74M. The largest seller was Visium Asset Management, exiting entirely with an estimated $1.37M sold.

  • 113 institutional investors held Rigel Pharmaceuticals (RIGL) as of Q1 2015, up from 96 in Q4 2014.
  • Funds reported $272M of Rigel Pharmaceuticals stock for Q1 2015, up 58% quarter-over-quarter.
  • 28 funds opened new Rigel Pharmaceuticals positions in Q1 2015 and 11 closed out, a net change of +17 holders.
  • The largest Rigel Pharmaceuticals buyer in Q1 2015 was Rhenman & Partners Asset Management, an estimated $2.74M added.
  • The largest Rigel Pharmaceuticals seller in Q1 2015 was Visium Asset Management, an estimated $1.37M sold.

Based on aggregated 13F filings for Q1 2015.